FGFR1 and ductal breast carcinoma in situ: Activation of FGFR1 signaling in DCIS.COM cells induces ERK1/2 activity, EMT, and cell proliferation in culture and promotes cell-derived xenograft tumor growth and progression to invasive cancer in mice.